12:00 AM
Jul 23, 2012
 |  BC Week In Review  |  Company News  |  Deals

Cadila Pharmaceuticals, Novavax, International Centre for Genetic Engineering and Biotechnology deal

Novavax and the center partnered to develop a malaria vaccine using Novavax's virus-like particle (VLP) technology in India with funding from India's Department of Biotechnology...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >